BeStock  

和黄医药 HCM

美股市值排名 #2555药品制造-专科与仿制
$15.16 +$0.96 (+6.76%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $15.16 0.00%
开盘$14.44
昨收$14.20
当日区间$14.44 – $15.31
成交量157.3K
市值$2.64B
市盈率(TTM)189.5
股息率–

基本面

最新报告季度:Q2, ended Jun 2021

营收$75.81M+37.3% YoY
营业利润-$80.53M-76.3% YoY
净利润-$59.49M-81.3% YoY
摊薄每股收益-$0.40-60.0% YoY
自由现金流-$51.82M-81.3% YoY
经营现金流-$48.96M

营收,近8个季度

$52.3MMar '18$49.9MJun '18$52.2MMar '19$50.0MJun '19$51.6MMar '20$55.2MJun '20$81.6MMar '21$75.8MJun '21

净利润,近8个季度

$-10.4MMar '18$-19.7MJun '18$-19.1MMar '19$-24.3MJun '19$-15.4MMar '20$-32.8MJun '20$-39.9MMar '21$-59.5MJun '21

各季度摊薄每股收益

-0.10Mar '18-0.15Jun '18-0.15Mar '19-0.20Jun '19-0.10Mar '20-0.25Jun '20-0.30Mar '21-0.40Jun '21

各季度自由现金流

$-32.2MMar '18$11.5MJun '18$-30.3MMar '19$-3.6MJun '19$-3.8MMar '20$-28.6MJun '20$-28.8MMar '21$-51.8MJun '21

年度营收

$228.0MFY20$356.1MFY21$426.4MFY22$838.0MFY23$630.2MFY24$548.5MFY25

盈利能力与资产负债表

毛利率41.6%
营业利润率-5.7%
净利率3.3%
净资产收益率1.4%
资产收益率1.0%
投入资本回报率1.3%
流动比率5.64
负债/资产比率26.6%
现金及投资$1.37B
总负债$94.51M
净现金(净负债)$1.28B
自由现金流/营收1.8%

营收构成

2025/FY 季度

按业务线

  • Oncology/Immunology$285.54M 52.1%
  • Other Ventures$262.97M 47.9%

按地区

  • People’s Republic of China (PRC)$407.45M 74.3%
  • US and Others$141.06M 25.7%

资产负债表

项目 2026 Q2 2025 ANNUAL 2025 Q4 2025 Q2 2024 ANNUAL
总资产 $1.74B $1.75B $1.75B $1.78B $1.27B
流动资产合计 $1.55B $1.57B $1.57B $1.59B $1.07B
现金及现金等价物与短期投资 $1.37B $1.37B $1.37B $1.36B $836.11M
-现金及现金等价物 $106.56M $71.33M $71.33M – $153.96M
-短期投资 $1.27B $1.30B $1.30B – $682.15M
-应收账款 $117.56M $126.75M $126.75M $146.97M $155.54M
-应收税款 $598,000.00 $4.57M $4.57M – $3.30M
-其他应收款 $7.01M $18.28M $18.28M – $12.21M
预付资产 $12.59M $9.34M $9.34M – $9.01M
存货 $40.84M $41.13M $41.13M – $50.40M
非流动资产合计 $183.02M $185.76M $185.76M $183.61M $207.64M
固定资产净值 $93.79M $97.65M $97.65M $94.57M $97.00M
-长期股权投资 $11.02M $10.87M $10.87M $3.65M $77.77M
其他非流动资产 $34.19M $20.09M $20.09M $85.40M $12.44M
负债合计 $461.46M $501.84M $501.84M $534.02M $502.34M
流动负债合计 $275.21M $315.78M $315.78M $342.41M $376.56M
应付款 $52.88M $64.32M $64.32M $264.79M $60.19M
-应付账款 $33.65M $45.53M $45.53M $43.73M $42.52M
-其他应付款 $19.23M $16.71M $16.71M $221.06M $16.12M
短期债务及融资租赁负债 $22.41M $27.85M $27.85M – $26.30M
-一年内到期债务 $22.41M $24.97M $24.97M – $23.37M
其他流动负债 $7.99M $250,000.00 $250,000.00 – $5.66M
非流动负债合计 $186.25M $186.06M $186.06M $191.60M $125.78M
长期应付账款及其他应付款 $5.69M $6.33M $6.33M – $6.62M
长期债务及融资租赁负债 $72.10M $70.04M $70.04M $93.44M $63.52M
-长期债务 $72.10M $68.19M $68.19M $93.44M $59.43M
非流动负债 $83.61M $79.96M $79.96M – –
其他非流动负债 $14.27M $9.35M $9.35M $98.16M $4.22M
股东权益合计 $1.27B $1.25B $1.25B $1.24B $771.85M
股东权益 $1.26B $1.24B $1.24B $1.23B $759.93M
股本 $87.23M $87.23M $87.23M – $87.16M
-普通股 $87.23M $87.23M $87.23M – $87.16M
资本公积 $1.54B $1.53B $1.53B – $1.52B
留存收益 -$362.72M -$378.64M -$378.64M – -$833.17M
少数股东权益 $14.19M $13.34M $13.34M $12.86M $11.92M
-固定资产原值 – $171.16M $171.16M – $156.31M
-累计折旧 – -$73.51M -$73.51M – -$59.32M
商誉及其他无形资产 – $3.11M $3.11M – $2.99M
-商誉 – $3.11M $3.11M – $2.99M
-应付税款合计 – $2.08M $2.08M – $1.55M
-一年内到期融资租赁负债 – $2.88M $2.88M – $2.93M
-长期融资租赁负债 – $1.85M $1.85M – $4.09M
其他流动资产 – – – $80.84M –
-可供出售证券 – – – – $5.00M

利润表

项目 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
报告营业总收入 $548.51M $630.20M $838.00M $426.41M $356.13M
营业总收入 $548.51M $630.20M $838.00M $426.41M $356.13M
营业成本 $336.35M $348.88M $384.45M $311.10M $258.23M
毛利润 $212.16M $281.32M $453.55M $115.31M $97.89M
营业费用 $247.86M $321.93M $432.04M $521.57M $425.89M
销售及管理费用 $103.03M $112.91M $133.18M $136.11M $127.13M
-销售及营销费用 $36.31M $48.62M $53.39M $43.93M $37.83M
-管理费用 $66.72M $64.30M $79.78M $92.17M $89.30M
研发费用 $148.30M $212.11M $302.00M $386.89M $299.09M
其他营业费用 $5.51M – – – –
营业利润 -$35.70M -$40.61M $21.51M -$406.26M -$328.00M
非经营性利息净收入(支出) $47.01M $37.21M $35.39M $8.95M $1.48M
非经营性利息收入 $49.88M $40.08M $36.15M $9.60M $2.08M
非经营性利息支出 $2.87M $2.87M $759,000.00 $652,000.00 $592,000.00
特殊收益(费用) $476.81M -$4.80M -$5.77M $0.00 $121.31M
-减:资本性资产减值 $89,000.00 $4.80M $5.77M $0.00 $0.00
-减:其他特殊支出 -$476.90M – – – -$121.31M
其他非经营性收入(支出) $3.54M $2.04M -$1.48M -$4.95M $342,000.00
税前利润 $498.69M -$1.11M $58.31M -$410.42M -$215.74M
税费 $63.61M $7.19M $4.51M -$283,000.00 $11.92M
净利润 $457.73M $38.17M $101.09M -$360.39M -$167.04M
持续经营利润 $457.73M $38.17M $101.09M -$360.39M -$167.04M
少数股东权益 $823,000.00 $441,000.00 $314,000.00 $449,000.00 $27.61M
归属母公司净利润 $456.91M $37.73M $100.78M -$360.84M -$194.65M
其他优先股股息 $0.00 $0.00 $0.00 $0.00 $0.00
归属普通股股东净利润 $456.91M $37.73M $100.78M -$360.84M -$194.65M
基本每股收益 $2.65 $0.20 $0.60 -$2.15 -$1.25
摊薄每股收益 $2.65 $0.20 $0.60 -$2.15 -$1.25

现金流量表

项目 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
经营活动现金流 -$64.66M $497,000.00 $219.26M -$268.60M -$204.22M
持续经营净利润 $457.73M $38.17M $101.09M -$360.39M -$167.04M
递延税款 $1.20M $3.61M $780,000.00 -$19.17M $6.90M
其他非现金项目 $1.57M -$4.95M $3.69M $2.74M -$3.68M
营运资金变动 -$60.86M -$62.17M $71.15M $58.70M $32.46M
-应收款变动 $24.22M -$41.57M -$13.05M -$2.38M -$41.39M
-存货变动 $9.54M -$772,000.00 $4.14M -$21.21M -$16.00M
-其他流动资产变动 -$48.02M -$27.37M $120.17M $644,000.00 $10.98M
-其他流动负债变动 -$775,000.00 $375,000.00 -$1.76M -$915,000.00 $3.08M
投资活动现金流净额 -$29.41M -$96.06M -$291.14M $296.59M -$306.32M
固定资产购置及出售净额 -$14.12M -$16.66M -$32.61M -$36.66M -$15.83M
无形资产购置及出售净额 -$10.00M $0.00 $0.00 – –
业务购买及出售净额 $608.50M $0.00 -$2.99M $324,000.00 $0.00
投资购置及出售净额 -$613.79M -$79.41M -$285.03M $316.44M -$449.61M
筹资活动现金流 $7.84M -$30.67M $48.66M -$82.76M $650.03M
债务发行及偿还净额 $6.26M $5.61M $61.71M -$9.17M -$579,000.00
普通股发行净额 $1.58M -$35.27M -$3.98M -$47.91M $690.01M
期末现金余额 $71.33M $153.96M $283.59M $313.28M $377.54M
现金净变动 -$86.23M -$126.23M -$23.22M -$54.77M $139.49M
期初现金余额 $153.96M $283.59M $313.28M $377.54M $235.63M
汇率变动影响 $3.60M -$3.40M -$6.47M -$9.49M $2.43M
自由现金流 -$88.81M -$17.44M $186.65M -$305.26M -$220.98M

讨论区

暂无评论——快来第一个聊聊 HCM。

登录后参与讨论。

Scroll to Top